Key facts
- Sentinel’s last known valuation is $3.5M (Mar 2025).
- It has raised $1.6M; the latest was Early Stage VC ($1.6M) in Mar 2025.
- Notable investors include SFC Capital, Scottish Enterprise, KCP Nominees, The University of Strathclyde.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Sentinel
- ·The full record, as it builds
Funding rounds
No funding rounds for Sentinel are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sentinel
Developer of a healthcare platform intended for workplace trauma prevention and management. The company brings together technology, commercial, and scientific expertise to help understand and manage primary and secondary trauma on a day-to-day basis, which directly affects mental and physical health, enabling employees to access online resources for trauma and trauma-related symptoms.
- Sector
- Healthcare
- HQ
- Glasgow, United Kingdom
- Founded
- 2024
- Employees
- 5
- Website
- sentinel-health.com/
- Ownership
- Privately Held (backing)
Sentinel doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sentinel shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sentinel in its N-PORT filings yet. We sweep new filings monthly.